Combination phosphodiesterase type 4 inhibitor and phosphodiesterase type 5 inhibitor treatment reduces non-voiding contraction in a rat model of overactive bladder.
Brian M BalogAbhilasha TangadaPooja ShethQi-Xiang SongBruna M CouriLeah L PorrasGary G DengMargot S DamaserPublished in: PloS one (2019)
A PDE4i and PDE5i combination treatment has potential benefit in reducing OAB symptoms, but future research is needed.
Keyphrases